Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
6
100%

Phase Distribution

0

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
6(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 26 (100.0%)

Trials by Status

terminated117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_2

Gemcabene for the Treatment of Pediatric NAFLD

NCT03436420
completedphase_2

Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)

NCT02722408
completedphase_2

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

NCT02944383
completedphase_2

A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins

NCT02634151
completedphase_2

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy

NCT02571257
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03436420Phase 2

Gemcabene for the Treatment of Pediatric NAFLD

Terminated
NCT02722408Phase 2

Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)

Completed
NCT02944383Phase 2

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

Completed
NCT02634151Phase 2

A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins

Completed
NCT02571257Phase 2

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy

Completed
NCT02591836Phase 2

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6